Evidence map›Paper›PMID 41375161›Full record

ArticleMolecules (Basel, Switzerland)2025

Novel Ni/Zn MOFs for Sorbitol Production via Catalytic Transfer Hydrogenation.

Vuyolwethu Tokoyi, Nirmala Deenadayalu

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Vuyolwethu TokoyiDepartment of Chemistry, Faculty of Applied Sciences, Durban University of Technology, Durban P.O. Box 1334, South Africa.ORCID 0000-0002-3349-2975
Nirmala DeenadayaluDepartment of Chemistry, Faculty of Applied Sciences, Durban University of Technology, Durban P.O. Box 1334, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Researchers continue to explore alternative catalysts that are more abundant and effective for hydrogenation reactions to produce sorbitol, such as those using nickel, ruthenium, or zirconium metal centers. This study examined the catalytic transfer hydrogenation of glucose to sorbitol using different alcohol hydrogen donors, specifically ethanol, isopropanol, 1,4-butanediol, and 1,4-cyclohexanediol, with the prepared Ni/Zn MOF catalysts. It also assessed how sacrificial alcohols affected the transformation and selectivity toward sorbitol. The results confirmed the successful catalytic activity and feasibility of this process using MOFs, especially the Ni-based one, which produced up to 51.8% sorbitol, while the Zn-based catalyst yielded 42.3% sorbitol in 1,4-cyclohexanediol. Sacrificial diols exhibited enhanced efficacy as hydrogen donors relative to short-chain alcohols, specifically terminal diols such as 1,4-butanediol and 1,4-cyclohexanediol, which provided substantial hydrogen donation potential and improved selectivity in the conversion of glucose to sorbitol, achieving maximum yields of 45.12% with 1,4-butanediol and 51.8% with 1,4-cyclohexanediol. Regarding the catalysts, both Ni and Zn MOFs improved the transfer hydrogenation process in sugar alcohol mixtures compared to aqueous solutions, and particularly the Ni MOF, with its high surface area and multiple active sites, enhanced the catalytic transformation process. The results clearly indicate that the structural and chemical properties of these alcohols affect the quantity of hydrogen generated and transferred, which is crucial for the efficient overall yield of sorbitol. This insight enhances the understanding of this engineered system and its potential future applications in sustainable biomass utilization.

Indexed as

and sacrificing alcoholscatalytic transfer hydrogenation (CTH)glucosemetal–organic framework (MOF)sorbitol

Identifiers

PMID41375161
PMCPMC12692985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.